V027-3002 Screening compound: N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide

V027-3002 Screening compound: N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide
V027-3002 Screening compound: N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V027-3002
N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V027-3002

Molecular Formula

C29H28N4O3 (C29 H28 N4 O3)

Compound Name

N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide

IUPAC name

N-cyclopropyl-N-({[1-(4-methoxyphenyl)-4-phenyl-1H-imidazol-2-yl]carbamoyl}methyl)-2-phenylacetamide

SMILES

COc(cc1)ccc1-n1c(NC(CN(C2CC2)C(Cc2ccccc2)=O)=O)nc(-c2ccccc2)c1

InChI

InChI=1S/C29H28N4O3/c1-36-25-16-14-24(15-17-25)33-19-26(22-10-6-3-7-11-22)30-29(33)31-27(34)20-32(23-12-13-23)28(35)18-21-8-4-2-5-9-21/h2-11,14-17,19,23H,12-13,18,20H2,1H3,(H,30,31,34)

InChI Key

JUCSYTBLNGOZLZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19822388

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

480.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.399

Distribution Coefficient, logD

5.399

Water Solubility, LogSw

-5.30

Polar Surface Area

58.985

Acid Dissociation Constant (pKa)

12.87

Base Dissociation Constant (pKb)

2.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.70

V027-3002 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V027-3002 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V027-3002?
Check Price and Availability of V027-3002, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V027-3002 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V027-3002
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V027-3002
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V027-3002 available by request